Survey Survey on the use of non-cryopreserved hematopoietic stem cells for autologous HSCT in adults Group Infectious Diseases Working Party (IDWP) Transplant Complications Working Party (TCWP) Principal investigator Emilian Snarski
Survey Current Management to Prevent and Treat CD19+ and BCMA+ CAR-T Cell Therapy-Related Complications Group Transplant Complications Working Party (TCWP) Principal investigator Olaf Penack
Frequency and Impact of Pre-Transplant Somatic Co-Occurring Mutations on Clinical Outcomes of Acute Myeloid Leukemia Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: On Behalf of the EBMT Acute Leukemia Working Party Group Acute Leukemia Working Party (ALWP) Principal investigator Ali Bazarbachi
Long term outcomes and relative mortality in survivors of allogeneic hematopoietic cell transplantation in acute myeloid leukemia: an analysis from the ALWP of the EBMT Group Acute Leukemia Working Party (ALWP) Principal investigator Vivek Patel
Outcome of haploidentical transplant in chronic granulomatous disease Group Inborn Errors Working Party (IEWP) Principal investigator Benedicte Neven
Prospective study on the incidence and outcome of HHV-6 encephalitis in patients who undergo allogeneic haploidentical HSCT Group Infectious Diseases Working Party (IDWP) Principal investigator Katia Perruccio
Comparison of outcomes after mismatched unrelated donor and haploidentical donor stem cell transplantation in aplastic anemia Group Severe Aplastic Anaemia Working Party (SAAWP) Principal investigator Juan Montoro
Nutritional care in patients undergoing hematopoietic stem cell transplantation Group Nursing Research Committee Cellular Therapy & Immunobiology Working Party (CTIWP) Principal investigator Paolo Pedrazzoli, Riccardo Caccialanza, Emanuele Cereda
Allo-HCT in CLL after multiple pathway inhibitors. Group Chronic Malignancies Working Party (CMWP) Principal investigator Michel van Gelder/Olivier Tournilhac
Outcomes following the use of PTCy in URD allo-HCT for CML Group Chronic Malignancies Working Party (CMWP) Principal investigator Guillermo Orti
Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres. Group Chronic Malignancies Working Party (CMWP) Principal investigator Patrick Hayden
Outcomes of Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with CALR-Mutated Myelofibrosis compared to those patients with a JAK2-mutation. Group Chronic Malignancies Working Party (CMWP) Principal investigator Juan Carlos Hernández-Boluda